[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362933-105":59,"doc-detail-362933-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-analysis-identified-sprr2d-as-a-potential-biomarker-for-tumor-prognosis-and-immune-microenvironment-infiltration-a-pan-cancer-perspective","Multi-omics analysis identified SPRR2D as a potential biomarker for tumor prognosis and immune microenvironment infiltration - a pan-cancer perspective","","Multi-omics analysis investigated SPRR2D as a candidate biomarker linking tumor progression, patient prognosis, and immune microenvironment features. Large-sample data mining first assessed expression and mutation profiles of the SPRR gene family across cancers, then evaluated the molecular functions of SPRR2D. Results showed SPRR2D is markedly overexpressed in multiple tumors, with diagnostic value across cancers and significant associations with survival via Cox regression. Expression also correlates with immune infiltration and may predict sensitivity to several targeted therapies. Overall conclusions highlight SPRR2D’s roles in tumorigenesis and drug sensitivity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-analysis-identified-sprr2d-as-a-potential-biomarker-for-tumor-prognosis-and-immune-microenvironment-infiltration-a-pan-cancer-perspective/362933/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-analysis-identified-sprr2d-as-a-potential-biomarker-for-tumor-prognosis-and-immune-microenvironment-infiltration-a-pan-cancer-perspective/362933.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research objective of the study?","Question",{"text":112,"@type":113},"The study aims to clarify molecular mechanisms of malignant tumor progression and identify key molecules and pathways, focusing on SPRR2D as a potential biomarker related to prognosis and immune microenvironment involvement.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was SPRR2D evaluated in the analysis?",{"text":117,"@type":113},"The work used large-sample data mining to assess SPRR family gene expression and mutation profiles across cancers, then concentrated on the molecular functions of SPRR2D and its relationships with diagnostic performance, survival, and immune infiltration.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about SPRR2D?",{"text":121,"@type":113},"Multi-omics experiments indicated SPRR2D is significantly overexpressed in multiple tumors, shows diagnostic efficacy across cancers, is associated with patient survival, and is closely related to tumor immune infiltration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362933,1791542883,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Future Science OA  \n2026, VOL. 12, nO. 1, 2653101  \n[https://doi.org/10.1080/20565623.2026.2653101](https://doi.org/10.1080/20565623.2026.2653101)  \nReseaRch aRticle  \nMulti-omics analysis identified SPRR2D as a potential biomarker for tumor prognosis and immune microenvironment infiltration:  \na pan-cancer perspective  \nYuan-Xiang shi   \ninstitute of clinical Medicine, Hunan Provincial People’s Hospital, the First Affiliated Hospital of Hunan normal university, changsha, china  \nABSTRACT  \nBackground: clarification of the molecular mechanism of malignant tumor progression, identification of the key signaling pathways and molecules involved in the processes of invasion and metastasis, and identification of new targets and strategies for effective tumor treatment are extremely important for scientific research and clinical application prospects. Methods: Based on large-sample data mining, we first evaluated the expression and mutation profiles of sPRR family genes across cancers and then focused on the molecular functions of sPRR2D across cancers.  \nResults: Multi-omics experiments revealed that sPRR2D is significantly overexpressed in various tumors, especially in lUsc. ROc curve analysis revealed that sPRR2D demonstrated significant diagnostic efficacy across cancers. cox regression analysis revealed that the expression of sPRR2D was associated with the survival time of patients with various tumors. Moreover, the expression of sPRR2D is closely related to tumor immune infiltration. GDsc data analysis revealed that the expression levels of sPRR1a, sPRR1B, sPRR2a, sPRR3, and sPRR2D are negatively correlated with the sensitivity to gefitinib, trametinib, bosutinib, afatinib, lapatinib, and erlotinib.  \nConclusions: From a multi-omics perspective, it was revealed that sPRR2D plays a significant role in regulating tumorigenesis and drug sensitivity in tumors.  \nPLAIN LANGUAGE SUMMARY  \nthis study aims to explore the key molecular mechanisms involved in tumor development and progression. By analyzing large-scale data, we focused on the role of a gene called sPRR2D in various types of cancer. Our findings show that sPRR2D is abnormally increased in multiple tumors, particularly in a type of lung cancer known as lung squamous cell carcinoma. the expression level of this gene is closely associated with patient survival time and may influence the interaction between tumors and the immune system. additionally, we found that the expression level of sPRR2D is negatively correlated with the effectiveness of certain targeted therapies. this study provides new insights into understanding tumor mechanismsand optimizing treatment strategies.  \nARTICLE HIGHLIGHTS  \n1. these findings highlight sPRR2D as a potential pan-cancer biomarker for early diagnosis and prognosis.  \n2. this study systematically evaluated the expression and mutation profiles of sPRR family genes across multiple cancer types based on large-sample data mining.  \n1. Introduction  \nARTICLE HISTORY  \nReceived 16 December 2025  \naccepted 26 March 2026  \nKEYWORDS  \nlung cancer; sPRR2D; pan-cancer; tumor microenvironment; drug sensitivity  \nin recent years, an increasing number of studies have investigated the small proline-rich protein (sPRR) family. the proline-rich structural features of s PRRs make them widely involved in biological processes such as cell differentiation, stress response, and barrier function regulation [1,2]; however, its expression pattern, molecular mechanism and clinical significance in tumors still need to be explored in depth. sPRR3 is significantly highly expressed in lung adenocarcinoma (lUaD) and affects patient prognosis by regulating immune-infiltrating cells  \nCONTACT Yuan-Xiang Shi  [yuanxiangshi@hunnu.edu.cn](yuanxiangshi@hunnu.edu.cn)  institute of clinical Medicine, Hunan Provincial People’s Hospital, the First Affiliated Hospital of Hunan normal university, no. 61, Jiefang West road, changsha, Hunan, 410000, china.  \n Supplemental data for this","cbCaihlrsPGMgbpg","https://ap.wps.com/l/cbCaihlrsPGMgbpg","pdf",2388636,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Plain Language Summary\n# Article Highlights\n# Introduction\n# Article History","[{\"question\":\"What is the main research objective of the study?\",\"answer\":\"The study aims to clarify molecular mechanisms of malignant tumor progression and identify key molecules and pathways, focusing on SPRR2D as a potential biomarker related to prognosis and immune microenvironment involvement.\"},{\"question\":\"How was SPRR2D evaluated in the analysis?\",\"answer\":\"The work used large-sample data mining to assess SPRR family gene expression and mutation profiles across cancers, then concentrated on the molecular functions of SPRR2D and its relationships with diagnostic performance, survival, and immune infiltration.\"},{\"question\":\"What did the results show about SPRR2D?\",\"answer\":\"Multi-omics experiments indicated SPRR2D is significantly overexpressed in multiple tumors, shows diagnostic efficacy across cancers, is associated with patient survival, and is closely related to tumor immune infiltration.\"}]","Multi-omics analysis identified SPRR2D as a potential biomarker for tumor prognosis and immune microenvironment infiltration - a pan-cancer perspective | PDF",1790149459,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca7d7b84e261d1522b377f4a76fc6385.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94e1b1dc556fe00667cd1167c9f146e7.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9b039ee05bf54377cee04b521f4ca21.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16f75270cecd2da36326b2031744e3c6.webp",980,1306]